Healthcare
M&A Advisory
Technology
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Apricus Biosciences. United States. Announced Date 23/05/2013. Closed Date 29/05/2013. Deal value: $17m. Confidentially marketed public offering. Industry: Apricus Biosciences is a pharmaceutical company specializing in the development and commercialization of innovative treatments in urology and rheumatology.